Sort by
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Neurologic Complications
100%
COVID-19
100%
CROI 2022
100%
People Living with HIV (PLHIV)
75%
Systemic Inflammation
50%
Cost-effectiveness
25%
Non-associated
25%
Neurodegeneration
25%
Neuroinflammation
25%
Cerebrospinal Fluid
25%
Comorbidity
25%
Cryptococcal Meningitis
25%
Myeloid Cells
25%
Central Nervous System
25%
Demyelination
25%
Neurotoxicity
25%
Cerebrospinal Fluid Biomarkers
25%
Neuroimaging Studies
25%
Randomized Controlled Trial
25%
Oxidative Stress
25%
Prognostic Value
25%
Lymphoid Cells
25%
Cognitive Decline
25%
Neurologic Syndrome
25%
Retroviral Infection
25%
Metabolic Pathway
25%
Opportunistic Infections
25%
Human Studies
25%
Pregenomic RNA (pgRNA)
25%
White Matter Damage
25%
Lateral Flow Assay
25%
Blood Fluid
25%
Inhibitor Therapy
25%
Childhood Trauma
25%
Brain Aging
25%
Neuroimaging Findings
25%
Polypharmacy
25%
Central Nervous System Effects
25%
Liposomal Amphotericin B
25%
Integrase Strand Transfer Inhibitor (INSTI)
25%
Cryptococcal Antigen
25%
Astrocyte Activation
25%
Endothelial Activation
25%
Childhood Exposure
25%
COVID-19 Infection
25%
Post-COVID-19
25%
Environmental Pollutants
25%
Chronic HIV Infection
25%
Term Analysis
25%
Tryptophan Metabolism
25%
Nucleocapsid Antigen
25%
Phenotypic Aging
25%
Single High Dose
25%
HIV Neuropathogenesis
25%
Stress Dysregulation
25%
Iron Dysregulation
25%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Pathogen
100%
Neurological Complication
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
42%
Cerebrospinal Fluid
28%
Infection
28%
Central Nervous System
28%
Biological Marker
14%
Cost-Effectiveness Analysis
14%
Neurodegeneration
14%
Neuroinflammation
14%
Myeloid Cell
14%
Randomized Controlled Trial
14%
Apoplexy
14%
Drug Megadose
14%
Oxidative Stress
14%
Lymphoid Cell
14%
Neurologic Disease
14%
Retrovirus Infection
14%
Human Immunodeficiency Virus Infection
14%
Human Study
14%
Neurotoxicity
14%
Astrocyte
14%
Demyelination
14%
Lateral Flow Assay
14%
Opportunistic Infection
14%
Virus RNA
14%
Pediatric Trauma
14%
Polypharmacy
14%
Parasympatholytic
14%
Cryptococcal Meningitis
14%
Iron
14%
Integrase
14%
Virus Nucleocapsid
14%
Amphotericin
14%
Post-COVID-19
14%
Tryptophan Metabolism
14%
Comorbidity
14%
Cognitive Decline
14%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Infectious Agent
100%
Neurological Complication
100%
SARS Coronavirus
100%
Infection
28%
Inflammation
28%
Biological Marker
14%
Cryptococcal Meningitis
14%
Nerve Degeneration
14%
Randomized Controlled Trial
14%
Neurotoxicity
14%
Neurologic Disease
14%
Opportunistic Infection
14%
Nervous System Inflammation
14%
Human Immunodeficiency Virus Infection
14%
Human Study
14%
Lateral Flow Assay
14%
Tryptophan
14%
Demyelination
14%
Virus RNA
14%
Retrovirus Infection
14%
Cholinergic Receptor Blocking Agent
14%
Cerebrovascular Accident
14%
Amphotericin
14%
Iron
14%
Polypharmacy
14%
Integrase
14%
Comorbidity
14%
Neuroscience
Human Immunodeficiency Virus
100%
SARS Coronavirus
100%
Central Nervous System
25%
Neurodegeneration
12%
Meningitis
12%
Metabolic Pathway
12%
Astrocyte
12%
Oxidative Stress
12%
Neurotoxicity
12%
Randomized Controlled Trial
12%
Myeloid
12%
Pediatric Trauma
12%
Tryptophan
12%
Integrase
12%
Cerebrovascular Accident
12%
Comorbidity
12%